IceCure's Advanced Multiprobe Cryoablation Technology Receives Patent Approval in Japan
November 25, 2024 - 22:01
IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
MORE NEWS
July 12, 2026 - 20:49
Education Technology Virginia nonprofit launches mobile tech education bus for underserved studentsTwo retired military cybersecurity experts in Virginia have launched a mobile education bus in the Hampton Roads area, aiming to bring technology training directly to students who lack access. The...
July 12, 2026 - 05:53
Florida Company Selected to Advance Lunar Environmental Monitoring TechnologyA company based in Florida has been picked to push forward the development of technology designed to monitor the harsh environment on the lunar surface. The selection is part of ongoing efforts to...
July 11, 2026 - 23:17
Eye In The Sky: Mission PD Using Technology To Lower Crime RateMission`s crime rate has dropped by 16 percent over the last six months, according to new data from the Texas Department of Public Safety`s Crime Reporting System. Police Chief Cesar Torres...
July 11, 2026 - 01:15
Rackspace Technology (RXT) Rebounds 22% After Brutal WeekA brutal stretch for Rackspace Technology ended with a sharp rebound on Friday, as shares surged 22% following a week that saw the stock get hammered by bad news and investor panic. The bounce came...